Iodoxamic acid

Iodoxamic acid
Clinical data
Trade namesEndobil
Other names3-[3-[2-[2-[2-[3-[(3-Carboxy-2,4,6-triiodophenyl)amino]-3-oxopropoxy]ethoxy]ethoxy]ethoxy]propanoylamino]-2,4,6-triiodobenzoic acid
ATC code
Identifiers
  • 3-{1-[(3-carboxy-2,4,6-triiodophenyl)carbamoyl]-3,6,9,12-tetraoxapentadecan-15-amido}-2,4,6-triiodobenzoic acid
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.045.875
Chemical and physical data
FormulaC26H26I6N2O10
Molar mass1287.925 g·mol−1
3D model (JSmol)
  • OC(=O)c(c1I)c(I)cc(I)c1NC(=O)CCOCCOCCOCCOCCC(=O)Nc(c2I)c(I)cc(I)c2C(=O)O

Iodoxamic acid (trade name Endobil) is an organoiodine compound used as a radiocontrast agent.[1] It features both a high iodine content as well as several hydrophilic groups.

See also

References

  1. ^ Mützel W, Taenzer V, Wolf R (1976). "Biotransformation of ioglycamic acid, iodoxamic acid and iotroxic acid in man". Investigative Radiology. 11 (6): 598–601. doi:10.1097/00004424-197611000-00018. PMID 1036733.
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.